Brief: Petros Pharmaceuticals Announces Positive Over-The-Counter Label Comprehension Study Results For Erectile Dysfunction Drug Stendra
08/12/2021 14:32
Dec 8 (Reuters) - Petros Pharmaceuticals Inc PTPI.O :
* PETROS PHARMACEUTICALS ANNOUNCES POSITIVE OVER-THE-COUNTER
(OTC)
LABEL COMPREHENSION STUDY RESULTS FOR ERECTILE DYSFUNCTION DRUG
STENDRA® (AVANAFIL)
* PETROS PHARMACEUTICALS INC - EARLY OTC DRAFT LABEL
COMPREHENSION
STUDY SHOWS POSITIVE LABEL COMPREHENSION OUTCOMES, CO TO
INITIATE SELF-SELECTION STUDY
Source text for Eikon: ID:nPnbWMcH3a
Further company coverage: PTPI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Petros Pharmaceuticals
See all newsBrief: Petros Pharmaceuticals Assigns All Assets To Pt Liquidation, For Benefit Of Creditors
Brief: Petros Pharmaceuticals’ STENDRA Pivotal Consumer Self-Selection Study for Over-the-Counter Access Demonstrates Statistical Significance
Brief: Petros Pharmaceuticals Files For Mixed Shelf Of Up To $100 Million - SEC Filing
Brief: Petros Pharmaceuticals Expands Online Distribution For Prescription STENDRA(R) Through New Agreement With Lemonaid Health
Brief: Petros Pharma Announces Partnership with Idea Evolver for Rx-to-OTC Switches & Digital Launch Solutions